•
Sep 30, 2012

West Pharma Q3 2012 Earnings Report

Total Revenue
$304M
Previous year: $294M
+3.5%
EPS
$0.26
Previous year: $0.51
-49.0%
Gross Profit
$90.4M
Previous year: $81.4M
+11.1%
Cash and Equivalents
$143M
Previous year: $162M
-11.6%
Free Cash Flow
$22.6M
Previous year: $15.5M
+45.8%
Total Assets
$1.53B
Previous year: $1.4B
+9.2%

West Pharma

West Pharma